P1589: AGENTS CONTRIBUTING TO SECONDARY IMMUNODEFICIENCY DEVELOPMENT IN PATIENTS WITH MULTIPLE MYELOMA, CHRONIC LYMPHOCYTIC LEUKEMIA AND NON-HODGKIN LYMPHOMA: A SYSTEMATIC LITERATURE REVIEW

• S. Jolles,
• S. Giralt,
• T. Kerre,
• H. M. Lazarus,
• S. S. Mustafa,
• R. Ria,
• D. C. Vinh

Affiliations

S. Jolles

1 University Hospital of Wales & Noah’s Ark Children’s Hospital for Wales Cardiff, Cardiff, United Kingdom

S. Giralt

2 Memorial Sloan Kettering Cancer Center, New York, United States of America

T. Kerre

3 Ghent University Hospital, Ghent, Belgium

H. M. Lazarus

4 Case Western Reserve University, Cleveland

S. S. Mustafa

5 Rochester Regional Health, Rochester, NY & University of Rochester, Rochester, United States of America

R. Ria

6 University of Bari Aldo Moro Medical School, Bari, Italy

D. C. Vinh

7 McGill University Health Centre, Montreal, Canada